ReShape Lifesciences Inc Cash Flow-to-Debt Ratio
ReShape Lifesciences Inc cash flow-to-debt ratio. ReShape Lifesciences Inc (RSLS) has a Cash Flow-to-Debt Ratio of -1.40x as of June 2025, meaning its operating cash flow of $-4.49 Million could theoretically repay -1% of its total liabilities ($3.20 Million) in one year. Check how high is ReShape Lifesciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ReShape Lifesciences Inc (2005–2024)
Cash flow-to-debt ratio of ReShape Lifesciences Inc from 2005 to 2024. Historical debt coverage capacity for ReShape Lifesciences Inc across 20 annual periods. Also explore RSLS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
ReShape Lifesciences Inc Cash Flow-to-Debt Ratio by Year (2005–2024)
ReShape Lifesciences Inc cash flow-to-debt ratio by year from 2005 to 2024. Year-by-year debt coverage analysis for ReShape Lifesciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of ReShape Lifesciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.24x | $-16.96 Million | $4.00 Million | ▼ -44.8% |
| 2022 | -2.93x | $-21.90 Million | $7.48 Million | ▼ -55.9% |
| 2021 | -1.88x | $-15.38 Million | $8.19 Million | ▼ -395.9% |
| 2020 | -0.38x | $-8.55 Million | $22.57 Million | ▲ +58.5% |
| 2019 | -0.91x | $-14.20 Million | $15.55 Million | ▲ +51.5% |
| 2018 | -1.88x | $-27.49 Million | $14.61 Million | ▲ +5.6% |
| 2017 | -1.99x | $-24.59 Million | $12.34 Million | ▲ +60.4% |
| 2016 | -5.04x | $-20.66 Million | $4.10 Million | ▼ -76.3% |
| 2015 | -2.86x | $-22.61 Million | $7.91 Million | ▼ -13.8% |
| 2014 | -2.51x | $-19.38 Million | $7.72 Million | ▼ -59.5% |
| 2013 | -1.57x | $-18.43 Million | $11.71 Million | ▲ +0.4% |
| 2012 | -1.58x | $-22.48 Million | $14.22 Million | ▲ +1.3% |
| 2011 | -1.60x | $-19.94 Million | $12.44 Million | ▼ -5.3% |
| 2010 | -1.52x | $-13.66 Million | $8.98 Million | ▲ +34.4% |
| 2009 | -2.32x | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -2.00x | $-33.67 Million | $16.87 Million | ▼ -17.6% |
| 2007 | -1.70x | $-23.37 Million | $13.77 Million | ▲ +21.7% |
| 2006 | -2.17x | $-16.23 Million | $7.49 Million | ▼ -102.1% |
| 2005 | -1.07x | $-10.28 Million | $9.59 Million | — |